<DOC>
	<DOC>NCT01880970</DOC>
	<brief_summary>The aim of this trial is to test the efficacy of an infant formula containing synbiotics on the prevention of gastro-intestinal infections.</brief_summary>
	<brief_title>Effect of Starter Formula on Infection Prevention</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Trematode Infections</mesh_term>
	<criteria>Healthy newborn infant Full term infant (≥ 37 weeks gestation; ≤ 42 weeks gestation) Age of infant is ≤ 13 days at the time of enrollment Birth weight ≥ 2500g and ≤ 4500g For the FF groups: The infant's mother has elected not to breastfeed For the BF group: The infant's mother has elected to fully breastfeed her baby, from enrollment to at least 3 months of age Having obtained his/her legal representative's informed consent Congenital illness or malformation that may affect normal growth (especially immunodeficiencies) Significant prenatal and/or postnatal diseases Perinatal antibiotic or infants on antibiotics at the time of inclusion Infants whose mother has had an acute infection during the last month of pregnancy Rehospitalisation for more than 2 days in the first 14 days of life (exceptionally, infants rehospitalized because of jaundice may be enrolled in the study) Receiving infant formula containing probiotics and/or prebiotics at the time of enrollment Newborn whose parents / caregivers cannot be expected to comply with treatment Newborn currently participating in another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>